BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 29486782)

  • 21. Sparing Cardiac Substructures With Optimized Volumetric Modulated Arc Therapy and Intensity Modulated Proton Therapy in Thoracic Radiation for Locally Advanced Non-small Cell Lung Cancer.
    Ferris MJ; Martin KS; Switchenko JM; Kayode OA; Wolf J; Dang Q; Press RH; Curran WJ; Higgins KA
    Pract Radiat Oncol; 2019; 9(5):e473-e481. PubMed ID: 31077884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proton arc reduces range uncertainty effects and improves conformality compared with photon volumetric modulated arc therapy in stereotactic body radiation therapy for non-small cell lung cancer.
    Seco J; Gu G; Marcelos T; Kooy H; Willers H
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):188-94. PubMed ID: 23920395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Feasibility of Pencil Beam Scanned Intensity Modulated Proton Therapy in Breath-hold for Locally Advanced Non-Small Cell Lung Cancer.
    Gorgisyan J; Munck Af Rosenschold P; Perrin R; Persson GF; Josipovic M; Belosi MF; Engelholm SA; Weber DC; Lomax AJ
    Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1121-1128. PubMed ID: 28964587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reproducibility of the lung anatomy under active breathing coordinator control: Dosimetric consequences for scanned proton treatments.
    den Otter LA; Kaza E; Kierkels RGJ; Meijers A; Ubbels FJF; Leach MO; Collins DJ; Langendijk JA; Knopf AC
    Med Phys; 2018 Dec; 45(12):5525-5534. PubMed ID: 30229930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dosimetric feasibility of 4DCT-ventilation imaging guided proton therapy for locally advanced non-small-cell lung cancer.
    Huang Q; Jabbour SK; Xiao Z; Yue N; Wang X; Cao H; Kuang Y; Zhang Y; Nie K
    Radiat Oncol; 2018 Apr; 13(1):78. PubMed ID: 29695284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lung Stereotactic Body Radiotherapy (SBRT) Using Spot-Scanning Proton Arc (SPArc) Therapy: A Feasibility Study.
    Liu G; Zhao L; Qin A; Grills I; Deraniyagala R; Stevens C; Zhang S; Yan D; Li X; Ding X
    Front Oncol; 2021; 11():664455. PubMed ID: 33968770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intensity-modulated proton therapy for elective nodal irradiation and involved-field radiation in the definitive treatment of locally advanced non-small-cell lung cancer: a dosimetric study.
    Kesarwala AH; Ko CJ; Ning H; Xanthopoulos E; Haglund KE; O'Meara WP; Simone CB; Rengan R
    Clin Lung Cancer; 2015 May; 16(3):237-44. PubMed ID: 25604729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is an analytical dose engine sufficient for intensity modulated proton therapy in lung cancer?
    Teoh S; Fiorini F; George B; Vallis KA; Van den Heuvel F
    Br J Radiol; 2020 Mar; 93(1107):20190583. PubMed ID: 31696729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel energy layer optimization framework for spot-scanning proton arc therapy.
    Gu W; Ruan D; Lyu Q; Zou W; Dong L; Sheng K
    Med Phys; 2020 Jun; 47(5):2072-2084. PubMed ID: 32040214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. On the interplay effects with proton scanning beams in stage III lung cancer.
    Li Y; Kardar L; Li X; Li H; Cao W; Chang JY; Liao L; Zhu RX; Sahoo N; Gillin M; Liao Z; Komaki R; Cox JD; Lim G; Zhang X
    Med Phys; 2014 Feb; 41(2):021721. PubMed ID: 24506612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
    Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
    J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical implementation of intensity modulated proton therapy for thoracic malignancies.
    Chang JY; Li H; Zhu XR; Liao Z; Zhao L; Liu A; Li Y; Sahoo N; Poenisch F; Gomez DR; Wu R; Gillin M; Zhang X
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):809-18. PubMed ID: 25260491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Feasibility of dynamic adaptive passive scattering proton therapy with computed tomography image guidance in the lung.
    Moriya S; Tachibana H; Hotta K; Nakamura N; Sakae T; Akimoto T
    Med Phys; 2017 Sep; 44(9):4474-4481. PubMed ID: 28665491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improving dosimetric outcome for hippocampus and cochlea sparing whole brain radiotherapy using spot-scanning proton arc therapy.
    Ding X; Zhou J; Li X; Blas K; Liu G; Wang Y; Qin A; Chinnaiyan P; Yan D; Stevens C; Grills I; Kabolizadeh P
    Acta Oncol; 2019 Apr; 58(4):483-490. PubMed ID: 30632851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intensity-modulated proton and carbon-ion radiotherapy using a fixed-beam system for locally advanced lung cancer: dosimetric comparison with x-ray radiotherapy and normal tissue complication probability (NTCP) evaluation.
    Ming X; Mao J; Ma N; Chen J; Wang W; Sheng Y; Wu K
    Phys Med Biol; 2024 Jan; 69(1):. PubMed ID: 38064747
    [No Abstract]   [Full Text] [Related]  

  • 36. Intensity-modulated proton therapy (IMPT) interplay effect evaluation of asymmetric breathing with simultaneous uncertainty considerations in patients with non-small cell lung cancer.
    Shan J; Yang Y; Schild SE; Daniels TB; Wong WW; Fatyga M; Bues M; Sio TT; Liu W
    Med Phys; 2020 Nov; 47(11):5428-5440. PubMed ID: 32964474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment planning comparison of IMPT, VMAT and 4π radiotherapy for prostate cases.
    Tran A; Zhang J; Woods K; Yu V; Nguyen D; Gustafson G; Rosen L; Sheng K
    Radiat Oncol; 2017 Jan; 12(1):10. PubMed ID: 28077128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dose-volume comparison of intensity modulated proton therapy and volumetric modulated arc therapy for cervical esophageal cancer.
    Kato T; Ono T; Narita Y; Komori S; Murakami M
    Med Dosim; 2022 Autumn; 47(3):216-221. PubMed ID: 35346554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proton stereotactic body radiation therapy for clinically challenging cases of centrally and superiorly located stage I non-small-cell lung cancer.
    Register SP; Zhang X; Mohan R; Chang JY
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1015-22. PubMed ID: 20615629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Density overwrites of internal tumor volumes in intensity modulated proton therapy plans for mobile lung tumors.
    Botas P; Grassberger C; Sharp G; Paganetti H
    Phys Med Biol; 2018 Jan; 63(3):035023. PubMed ID: 29219119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.